Pharmaceuticals

Helsinn Group Signs Exclusive Agreement with Mundipharma for Distribution and Licence of Anamorelin in Mainland China, Hong Kong and Macao

SINGAPORE, March 26, 2015 /PRNewswire/ -- Helsinn, a Swiss Group focused on building quality cancer care, and Mundipharma, today announce that they have entered into a distribution and license agreement for the exclusive rights to anamorelin in Mainland China, Hong Kong and Macao. Under the terms...

2015-03-26 15:00 1870

Finesse Solutions Announces Cellworld 2015

SANTA CLARA, Calif., March 26, 2015 /PRNewswire/ -- Finesse Solutions announced Cellworld 2015, a new event that is specifically designed for innovators, visionaries and senior executives in bio-processing. The two day conference, by invitation only, will be held at the Hyatt Regency inDowntown ...

2015-03-26 15:00 2136

Infinitus Re-Awarded "Aon Hewitt Best Employer-China"

SHANGHAI, March 24, 2015 /PRNewswire/ -- On 20 March 2015, Infinitus (China), member of LKK Health Products Group (LKKHPG), was awarded "Aon Hewitt Best Employer-China 2015". Infinitus (China) Awarded "Aon Hewitt Best Employer-China 2015" T...

2015-03-24 15:53 1961

Ergomed Strengthens Presence in Asia to Meet Increasing Demand for Drug Development Services

LONDON, March 24, 2015 /PRNewswire/ -- Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announced the opening of a new office inTaiwan. This expansion stren...

2015-03-24 10:16 1817

Marken Announces New Shanghai Office

RESEARCH TRIANGLE PARK, North Carolina, March 24, 2015 /PRNewswire/ -- Marken announced today the opening of their brand new office inShanghai, China. The logistics operations center will serve many of Marken's pharmaceutical clients inShanghai, Suzhou and surrounding areas. Logo - http://photos...

2015-03-24 06:38 1461

Sirtex Reports Preliminary SIRFLOX Study Results

SYDNEY, March 23, 2015 /PRNewswire/ -- * In the first-line treatment of non-resectable metastatic colorectal cancer:    * SIRFLOX study does not show a statistically significant improvement in overall Progression-Free Survival.   * SIRFLOX study does show a statistically significant improvem...

2015-03-23 16:07 1400

Nuvesse Skin Therapies Announces Presentation of Top-line Clinical Data Supporting Ability of Cellulation™ Technology to Actively Deliver Topically Applied Skin Therapies Faster and Deeper

CASTRO VALLEY, Calif., March 23, 2015 /PRNewswire/ -- Nuvesse Skin Therapies, a leading cosmetic skin care company, today announced the presentation of positive data demonstrating the ability of the company's CellulationTM Technology to actively deliver topically applied skin therapies into the ...

2015-03-23 08:00 1740

Nutraceutical Industry Development Conference will be Organised during HNC 2015

SHANGHAI, March 20, 2015 /PRNewswire/ -- From June 24-26, 2015, the Nutraceutical Industry Development Conference - China Market Entry Strategy for Foreign Dietary Supplements, will be organised during HNC 2015, the leading health expo, at SNIEC inShanghai, China. As the organiser, UBM Sinoexpo ...

2015-03-20 09:00 1535

Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer

HONG KONG, March 18, 2015 /PRNewswire/ -- Celgene announced today that a new treatment option for late-stage pancreatic cancer is now available for use in Hong Kong. Approved by the Department of Health, Abraxane® (paclitaxel formulated as albumin-bound nanoparticles) is indicated for use in combi...

2015-03-18 14:00 2979

Breast Cancer: Targeted Therapies Offer Novel Treatment Modalities

LONDON, March 17, 2015 /PRNewswire/ -- Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about52 drugs in dev...

2015-03-17 18:57 1064

Sirtex Reports Preliminary SIRFLOX Study Results

SYDNEY, March 17, 2015 /PRNewswire/ -- * In the first-line treatment of non-resectable metastatic colorectal cancer:  * SIRFLOX study does not show a statistically significant improvement in overall Progression-Free Survival.  * SIRFLOX study does show a statistically significant improvement ...

2015-03-17 15:28 2297

A New Therapeutic Vaccine Successfully Developed Against Rabies

BEIJING, March 16, 2015 /PRNewswire/ -- Yisheng Biopharma Co., Ltd.  ("Yisheng Biopharma"), a biopharmaceutical company focusing on the research, development, manufacturing, sales and marketing of vaccine products, announced that a new vaccine for the post exposure treatment of the rabies infecti...

2015-03-16 22:53 1715

Samsung Bioepis Submits Marketing Authorization Application For SB2, A Remicade (Infliximab) Biosimilar Candidate, To The European Medicines Agency

INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization Application (MAA) for SB2, its Remicade (Infliximab) biosimilar candidate, has been submitted to the European Medicines Agency (EMA). This is the second biosimilar cand...

2015-03-13 20:00 2522

China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development

ST. LOUIS, March 11, 2015 /PRNewswire/ -- Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc ), its custom manufacturing services business unit, entered a commercial sales and service contract with leading...

2015-03-11 19:00 1824

Green Cross Expands Cell Therapy Business in China

YONGIN, South Korea, March 11, 2015 /PRNewswire/ -- Green Cross, a South Korean biopharmaceutical company, today announced that it had signed MOU on the 6th of March with theGuizhou provincial government of China for the investment in the cell therapy sector inChina. Under the MOU, the company ...

2015-03-11 15:56 1703

Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

OSAKA, Japan, March 10, 2015 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Synd...

2015-03-10 07:01 1217

DKSH Expands Asian Market for Sumitomo Dainippon Pharma

HONG KONG, March 5, 2015 /PRNewswire/ -- DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business inAsia, will provide marketing, sales and regulatory services as well as distribution and logistics for lurasidone hydrochloride (generic name, "lurasi...

2015-03-05 16:04 2232

Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan

KUALA LUMPUR, Malaysia, March 4, 2015 /PRNewswire/ -- The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety but also ensures identity, convenience of handling, and proper delivery. As patent loss delivers more generics into the ma...

2015-03-04 13:18 1306

2015 Manufacturing Leadership Award Winners Announced

MOUNTAIN VIEW, Calif., March 4, 2015 /PRNewswire/ -- Frost & Sullivan's Manufacturing Leadership (ML) Council today recognized world-class manufacturing companies and individual leaders as winners of the 2015 Manufacturing Leadership Awards. ...

2015-03-04 00:42 3087

Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics

MOUNTAIN VIEW, Calif., March 3, 2015 /PRNewswire/ -- Based on its recent analysis of the enhanced drug discovery market, Frost & Sullivan recognizes Neopeutics, Inc. with the 2015 North America Frost & Sullivan Award for Technology Leadership. Neopeutics has demonstrated a remarkable ability to ...

2015-03-03 22:00 1946
1 ... 93949596979899 ... 105